Yokochi T, Nakashima I, Kato N
Microbiol Immunol. 1980;24(2):141-54. doi: 10.1111/j.1348-0421.1980.tb00572.x.
Changes in the number of cells and the weight of various lymphoid organs of mice, such as the regional lymph node (right inguinal node), spleen, thymus, bone marrow, and peripheral blood, were followed after the subcutaneous injection of the capsular polysaccharide of Klebsiella pneumoniae (CPS-K). For comparison, the changes after injection of various polyclonal lymphocyte activators (PLA) including various preparations of bacterial lipopolysaccharide (LPS) were concurrently studied. The number of cells of all of the lymphoid organs tested and that of nucleated cells in the peripheral blood decreased significantly within a few days after injection of CPS-K, and increased later. Above all, the increase in the number of cells and in the weight of the regional lymph node was most prominent (about 10 times larger than that of the normal control). Such a marked increase in the number of cells of the regional lymph node was not induced by the injection of any preparation of LPS or any other PLA tested. The initial decrease in the number of cells after CPS-K injection was most marked and long lasting in the thymus. Although LPS prepared by Westphal's method from Escherichia coli 055 or Salmonella enteritidis exhibited a stronger decreasing effect on the number of cells of the thymus, the effect of LPS prepared by Westphal's method from E. coli O111 or that by Boivin's method from E. coli O55 was similar to that of CPS-K. It is concluded therefore that CPS-K has the ability to decrease the number of cells of various lymphoid organs, especially that of the thymus, initially after injection, which is a property in common with LPS, and CPS-K has a unique ability to increase markedly the cells of various lymphoid organs, especially those of the regional lymph node, at later stages after injection. Considering that CPS-K exhibits a much stronger adjuvant effect on the antibody response than does LPS or other polyclonal lymphocyte activators, it is suggested that this extraordinarily potent activity of CPS-K in increasing the number of cells of the regional lymph node is closely related to its strong adjuvant action.
皮下注射肺炎克雷伯菌荚膜多糖(CPS-K)后,对小鼠的各种淋巴器官(如局部淋巴结(右腹股沟淋巴结)、脾脏、胸腺、骨髓和外周血)的细胞数量和重量变化进行了跟踪。为作比较,同时研究了注射包括各种细菌脂多糖(LPS)制剂在内的各种多克隆淋巴细胞激活剂(PLA)后的变化。注射CPS-K后几天内,所有测试的淋巴器官的细胞数量以及外周血中有核细胞数量均显著减少,随后增加。最重要的是,局部淋巴结的细胞数量和重量增加最为显著(比正常对照大约大10倍)。注射任何测试的LPS制剂或任何其他PLA均未引起局部淋巴结细胞数量如此显著的增加。CPS-K注射后细胞数量的最初减少在胸腺中最为明显且持续时间长。尽管用Westphal方法从大肠杆菌O55或肠炎沙门氏菌制备的LPS对胸腺细胞数量的减少作用更强,但用Westphal方法从大肠杆菌O111制备的LPS或用Boivin方法从大肠杆菌O55制备的LPS的作用与CPS-K相似。因此得出结论,CPS-K具有在注射后最初减少各种淋巴器官,尤其是胸腺细胞数量的能力,这是与LPS共有的特性,并且CPS-K具有在注射后期显著增加各种淋巴器官,尤其是局部淋巴结细胞数量的独特能力。鉴于CPS-K对抗体反应的佐剂作用比LPS或其他多克隆淋巴细胞激活剂强得多,提示CPS-K在增加局部淋巴结细胞数量方面的这种极强活性与其强大的佐剂作用密切相关。